<DOC>
	<DOCNO>NCT03048591</DOCNO>
	<brief_summary>Through research confirm effectiveness safety use electroacupuncture treatment chemotherapy-induced peripheral neuropathy .</brief_summary>
	<brief_title>The Exploratory Study Electroacupuncture Treatment Peripheral Neuropathy Induced Platinum Based Chemotherapy Drugs</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<criteria>1 . The histopathological / cellular pathology result prove malignancy tumor patient receive chemotherapy treatment . 2 . 15weeks completion chemotherapy , limb still feel abnormal symptom fulfill World Health Organization ( WHO ) grade 2 . 3. zubrod Eastern Cooperative Oncology GroupWHO ( ZPS ) grade 02 , cardiac function , liver function renal function significantly abnormal , survival period patient expect 6 month . 4 . Gender unrestricted , age 18 80 year old . 5 . Voluntary participation study , sign informed consent , willing comply randomize grouping , followup . 1 . Patients suffer peripheral neuropathy due infection , radiotherapy , HIV , chronic alcoholism , hypothyroidism , diabetes , paraneoplastic syndrome disease ; suffer nervous system disease . 2 . Patients treat drug may lead neurotoxicity . 3 . Patients blood coagulation disorder . 4 . Pregnancy lactate woman . 5 . Patients infection , scar defect near acupoint site . 6 . Received intervention prevention treatment peripheral neuropathy 2 week screen receive traditional Chinese medicine ( acupuncture , moxibustion , cup , Chinese medicine therapy one month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>